| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |